Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Depressive Disorder, Major”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00866294
What this trial is testing

Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)

Who this might be right for
Depressive Disorder
GlaxoSmithKline 416
Not applicableStudy completedNCT01640483
What this trial is testing

Differential Efficacy of Supportive and Interpretative Psychodynamic Techniques for Dependent and Self-critical Depressive Patients

Who this might be right for
Major Depressive Disorder
University Ghent 120
Large-scale testing (Phase 3)Study completedNCT00789854
What this trial is testing

Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients

Who this might be right for
Major Depressive DisorderTreatment Resistant Depression
AstraZeneca 688
Post-approval studies (Phase 4)UnknownNCT03666494
What this trial is testing

Ketamine Co-induction for Patients With Major Depressive Disorder

Who this might be right for
KetamineDepressionAnesthesia
University of Saskatchewan 50
Large-scale testing (Phase 3)Study completedNCT02013531
What this trial is testing

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

Who this might be right for
Major Depressive DisorderAnxiety
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Early research (Phase 1)Study completedNCT00745017
What this trial is testing

Stress Generation and Recurrent Depression: The Role of Differential Treatment Response

Who this might be right for
DepressionMajor Depressive Disorder
Centre for Addiction and Mental Health 72
Not applicableUnknownNCT04524260
What this trial is testing

The Effects of Perioperative Painting Art Therapy (LOM® Solution Centered Art Therapy) in Surgical Patients

Who this might be right for
Lower Gastrointestinal Neoplasms BenignPancreas CancerPosttraumatic Stress Disorder+1 more
University of Zurich 80
Large-scale testing (Phase 3)Study completedNCT01737268
What this trial is testing

Long-term Study of FK949E in Elderly Bipolar Disorder Patients

Who this might be right for
Bipolar DisorderElderly
Astellas Pharma Inc 20
Testing effectiveness (Phase 2)Study completedNCT00214682
What this trial is testing

Beyond Ageing Project: A Study for the Prevention of Depression

Who this might be right for
DepressionDepressive Disorder
Australian National University 909
Post-approval studies (Phase 4)Ended earlyNCT02969876
What this trial is testing

Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine

Who this might be right for
Depressive DisorderMajor DepressionDepression+1 more
Massachusetts General Hospital 2
Post-approval studies (Phase 4)Study completedNCT00251043
What this trial is testing

Antepartum Study on Use of Interpersonal Psychotherapy at 3 New York City Site

Who this might be right for
Depression
New York State Psychiatric Institute 142
Large-scale testing (Phase 3)Looking for participantsNCT07088380
What this trial is testing

Ketamine Augmentation of ECT in Treatment-Resistant Depression

Who this might be right for
Major Depressive DisorderTreatment Resistant Depression
Università Vita-Salute San Raffaele 30
Very early researchStudy completedNCT04977674
What this trial is testing

Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine

Who this might be right for
Depressive Disorder, Treatment-Resistant
King's College London 27
Early research (Phase 1)Study completedNCT05905120
What this trial is testing

Assessing Dopamine Transporter Occupancy in the Healthy Adult Brain With Toludivenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)

Who this might be right for
Major Depressive Disorder
Shanghai Mental Health Center 6
Testing effectiveness (Phase 2)Study completedNCT05118750
What this trial is testing

ALTO-300 in Depression

Who this might be right for
Major Depressive Disorder
Alto Neuroscience 91
Early research (Phase 1)Study completedNCT01380691
What this trial is testing

LY2216684 in Healthy Participants

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 28
Not applicableLooking for participantsNCT05295888
What this trial is testing

Temporal Interference and Depression

Who this might be right for
Major Depressive Disorder
Unity Health Toronto 30
Not applicableLooking for participantsNCT07316803
What this trial is testing

Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness

Who this might be right for
Severe Mental IllnessSchizophreniaBipolar Disorder+1 more
Centre hospitalier de Ville-Evrard, France 20
Post-approval studies (Phase 4)Study completedNCT01902004
What this trial is testing

Brain Aging and Treatment Response in Geriatric Depression

Who this might be right for
Mild Cognitive Impairment (MCI)Depression
University of California, Los Angeles 115
Not applicableNot Yet RecruitingNCT06743633
What this trial is testing

Association of Beta Blocker Use with Depressive Outcomes

Who this might be right for
Depression - Major Depressive Disorder
Chitkara University 1,136
Next Page